Literature DB >> 17366006

The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden.

Gunnar Jacobsson1, Sina Dashti, Thomas Wahlberg, Rune Andersson.   

Abstract

We conducted a prospective study of all cases of invasive Staphylococcus aureus infections (ISA) in the catchment area of Skaraborg Hospital (population 255,109) in western Sweden from March 2003 to February 2005. The annual incidence was 33.9 cases/100,000 population. Of these, 49% were classified as community-acquired, 32% as nosocomial and 19% as health care-associated. The mean age was 65 y. We registered children (age < or = 18 y) in 13 episodes. The most common predisposing illnesses/conditions were persons undergoing haemodialysis (relative risk 291), peritoneal dialysis (relative risk 204), persons with rheumatoid arthritis (relative risk 9), diabetes mellitus (relative risk 8), and cancer (relative risk 7). The patients were treated at various departments; only 18% of the episodes were primarily cared for at a department of infectious diseases. The most common diagnosis was soft tissue infection (27% of the episodes), bacteraemia without focus (19%), arthritis (15%), and line-associated infection (14%). A total of 197 invasive isolates was obtained, the vast majority from blood, in 141 of 170 episodes. We documented the wide spectrum of signs and symptoms. One- quarter of the patients had no history of fever, and one-third of the bacteraemia patients had normal white blood cell count (<10 x 10(9)/l) at presentation. All cases were of MSSA (methicillin-sensitive Staphylococcus aureus).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366006     DOI: 10.1080/00365540600810026

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  35 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Outcome for invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; E Gustafsson; R Andersson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

3.  Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation.

Authors:  Jakub Kwiecinski; Manli Na; Anders Jarneborn; Gunnar Jacobsson; Marijke Peetermans; Peter Verhamme; Tao Jin
Journal:  Appl Environ Microbiol       Date:  2015-10-30       Impact factor: 4.792

4.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

5.  MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood.

Authors:  B Schweickert; I Noll; M Feig; H Claus; G Krause; E Velasco; T Eckmanns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

6.  Galectin-3 Is a Target for Proteases Involved in the Virulence of Staphylococcus aureus.

Authors:  Jonas Elmwall; Jakub Kwiecinski; Manli Na; Abukar Ahmed Ali; Veronica Osla; Lindsey N Shaw; Wanzhong Wang; Karin Sävman; Elisabet Josefsson; Johan Bylund; Tao Jin; Amanda Welin; Anna Karlsson
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

7.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

8.  Staphylococcus aureus sepsis in rheumatoid arthritis.

Authors:  Michael Sams; Margaret A Olsen; Reeti Joshi; Prabha Ranganathan
Journal:  Rheumatol Int       Date:  2015-03-11       Impact factor: 2.631

Review 9.  Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.

Authors:  K Z Vardakas; I Kontopidis; I D Gkegkes; P I Rafailidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-20       Impact factor: 3.267

10.  Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.

Authors:  Kanokporn Mongkolrattanothai; Jean C Aldag; Peggy Mankin; Barry M Gray
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.